Viewing Study NCT05046795


Ignite Creation Date: 2025-12-24 @ 1:56 PM
Ignite Modification Date: 2025-12-30 @ 9:43 PM
Study NCT ID: NCT05046795
Status: COMPLETED
Last Update Posted: 2024-11-01
First Post: 2021-09-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
Sponsor: Mylan Pharma UK Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COPD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Revefenacin View
None Long-acting muscarinic receptor antagonist(LAMA) View